Stocklytics Platform
Asset logo for symbol RENE
Cartesian Growth Corporation II
RENE34
$11.460.00%$0.00
Asset logo for symbol RENE
RENE34

$11.46

0.00%
Key Stats
Open$11.46
Prev. Close$11.47
EPS0.36
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$247.98M
LOWHIGH
Day Range11.46
11.47
52 Week Range10.80
11.58
Ratios
Revenue-
EBITDA Margin %-
EPS0.36
Fundamentals
Gross Profit-
EBITDA
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

RENE-
US Financial Services Sector-
US Market-
warning

RENE / Market

RENE lose to the US Market which returned 0.54% over the last twenty four hours.
warning

RENE / Financial Services Sector

RENE lose to the US Financial Services sector which returned 0.69% over the last twenty four hours.

Cartesian Growth Corporation II (RENE) Statistics

Cartesian Growth Corporation II, also known as RENE, is a company that operates in the growth sector. The company focuses on investing in companies with strong potential for growth and value creation. As of the latest statistics, RENE stock has shown impressive performance. Its valuation metrics indicate that the stock is attractively priced, making it a potentially lucrative investment. When examining the fundamentals of RENE, it becomes clear that the company is well-positioned for future success. With its strong revenue per share and impressive Enterprise to EBITDA ratio, RENE demonstrates its ability to generate substantial profits. Another positive aspect of RENE's fundamentals is its healthy profit margin, indicating efficient management and cost control.
In terms of financial health, RENE has managed its total debt effectively, which is a positive indicator for investors. Additionally, RENE's gross profit is evidence of its ability to generate revenue and effectively manage costs. Overall, RENE is a company that exhibits strong growth potential and is backed by impressive financial metrics. Leading the company is its CEO, who brings extensive experience and knowledge to the table. With a track record of success, the CEO is focused on driving RENE's growth and maximizing shareholder value. In conclusion, Cartesian Growth Corporation II, also known as RENE, is an exciting investment opportunity in the growth sector.
add Cartesian Growth Corporation II to watchlist

Keep an eye on Cartesian Growth Corporation II

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Cartesian Growth Corporation II (RENE) stock's performance compared to its sector and the market over the past year?

Over the past year, Cartesian Growth Corporation II (RENE) has experienced a price change of . Compared to the Financial Services sector, which saw a change of 32.39%, Cartesian Growth Corporation II has underperformed compared to its sector, indicating its relative standing within the Financial Services sector. Against the broader market's change of 31.07%, it has fallen short of the market average. This comparison highlights Cartesian Growth Corporation II's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Cartesian Growth Corporation II (RENE) stock?

The PE (Price to Earnings) ratio of Cartesian Growth Corporation II (RENE) is currently 31.83. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Cartesian Growth Corporation II (RENE) stock?

The Earnings Per Share (EPS) for Cartesian Growth Corporation II (RENE), calculated on a diluted basis, is $0.36. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Cartesian Growth Corporation II (RENE) stock?

The operating margin for Cartesian Growth Corporation II (RENE) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Cartesian Growth Corporation II (RENE) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Cartesian Growth Corporation II (RENE) is $0. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Cartesian Growth Corporation II (RENE) have?

Cartesian Growth Corporation II (RENE) has a total debt of $5.14M. The net debt, which accounts for cash and cash equivalents against the total debt, is $5.1M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media